NeoGenomics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 66,467 59,867 43,484 34,371
Cost of Revenue 34,730 33,031 24,056 18,588
Gross Profit 31,737 26,836 19,428 15,783
Operating Expenses
Research and Development 2,440 2,281 543 -
Sales, General and Admin. 26,123 23,344 19,294 18,746
Non-Recurring Items - - - -
Other - - - -
Operating Income 3,174 1,211 (409) (2,963)
Income From Continuing Operations
Add'l Income/Expense Items - - - 370
Earnings Before Interest and Tax 2,185 65 (1,177) (2,593)
Interest Expense - - - 710
Earnings Before Tax 2,185 65 (1,177) (3,303)
Income Tax 152 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,033 65 (1,177) (3,303)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,033 65 (1,177) (3,303)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,033 65 (1,177) (3,303)